Viswanathan Ramakrishnan to Aged
This is a "connection" page, showing publications Viswanathan Ramakrishnan has written about Aged.
Connection Strength
0.160
-
Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virginia. Seizure. 2009 Jul; 18(6):405-11.
Score: 0.027
-
Preliminary results of subintimal angioplasty for limb salvage in lower extremities with severe chronic ischemia and limb-threatening ischemia. J Vasc Surg. 2006 Dec; 44(6):1239-46.
Score: 0.023
-
The Care-coordination Approach to Learning Lupus Self-Management: a patient navigator intervention for systemic lupus inpatients. Lupus Sci Med. 2021 05; 8(1).
Score: 0.015
-
Phase I Safety Trial: Extended Daily Peripheral Sensory Stimulation Using a Wrist-Worn Vibrator in Stroke Survivors. Transl Stroke Res. 2020 04; 11(2):204-213.
Score: 0.014
-
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 May; 14(5):682-689.
Score: 0.012
-
Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. J Allergy Clin Immunol. 2016 Apr; 137(4):1054-1062.
Score: 0.011
-
Delayed grip relaxation and altered modulation of intracortical inhibition with aging. Exp Brain Res. 2016 Apr; 234(4):985-95.
Score: 0.011
-
Transcranial Direct Current Stimulation Post-Stroke Upper Extremity Motor Recovery Studies Exhibit a Dose-Response Relationship. Brain Stimul. 2016 Jan-Feb; 9(1):16-26.
Score: 0.010
-
Approaches for dealing with various sources of overdispersion in modeling count data: Scale adjustment versus modeling. Stat Methods Med Res. 2017 Aug; 26(4):1802-1823.
Score: 0.010
-
Identification of chronic rhinosinusitis phenotypes using cluster analysis. Int Forum Allergy Rhinol. 2015 May; 5(5):399-407.
Score: 0.010
-
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest. 2013 Nov; 144(5):1578-1586.
Score: 0.009
-
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. Clin Cancer Res. 2013 Apr 01; 19(7):1873-83.
Score: 0.009